Conigen Bioscience, Inc

Conigen Bioscience Inc. is a science-driven life science tools company that integrates state-of-art immunology, virology, molecular biology and cell biology to create new reagents and high-quality assays, for a broad range of novel targets to enable new drug modalities, from discovery to development to manufacturing. Dr. Jean Qiu is the Chief Executive Officer of Conigen Bioscience, Inc. Previously, Dr. Qiu was the Founder & Chief Technology Officer of Nexcelom Bioscience. From the basement of her home, she started Nexcelom in 2003, with the goal of automating manual cell counting on the biologists lab bench using image cytometry technologies. Nexcelom product portfolio expanded to include cell counting and cell-based assay instruments, software, consumables and reagent kits, which are distributed globally. Nexcelom was acquired by PerkinElmer in 2021. Dr. Qiu has published over 50 papers in peer-reviewed academic journals and holds more than 35 patents. https://www.linkedin.com/in...